Background: HIV infection depletes gut mucosa, which leads to bacterial translocation and T-cell dysfunction. Despite effective ART, CD4+ T-cell depletion and HIV replication persist in the gut. We evaluated the impact of quadruple ART on systemic/mucosal immunity and bacterial translocation.
Methods: 33 ART-naïve HIV patients (pts) were randomized to efavirenz (EFV), maraviroc (MRV) or MRV + raltegravir (MRV+RAL), each with TDF/FTC. Colon and duodenal biopsies were obtained at baseline (BL) and at 9 months of suppressive ART. Lymphocyte subsets and activation phenotypes (CD38+/HLA-DR+) were measured in peripheral blood (PB) at BL, month 3, 6, and 9 and in duodenum, and colon at BL and month 9 by flow cytometry. Plasma IL-6, lipoteichoic acid (LTA), sCD14 and zonulin were measured by ELISA. Immunohistochemistry (IHC) of duodenal biopsies was performed to determine T cells/mm2. Linear mixed models were used to evaluate the association of treatment group with changes in continuous variables.
Results: 26 HIV pts completed the follow-up: 8 on the EFV arm, 10 on the MRV arm and 8 on the MVC+RAL arm. Median age was 37 years [25-42]. Median BL PB CD4 counts were 322, 440 and 453 cell/mm3, respectively (between-group comparisons, P=ns.). All pts achieved complete HIV suppression.
Levels of IL-6, sCD14 and LTA, but not zonulin, improved during the study (P=0.059, 0.038, 0.006 and 0.304). The MVC+RAL group showed greater improvements of sCD14 (Figure 1A, P=0.039) and zonulin (P=0.015) levels. IHC showed that while both CD4 and CD8 T cell density ameliorated in duodenum, the CD4 subset remained far more impaired than the CD8 subset (between-groups differences, P=ns.). T-cell activation significantly decreased in all compartments during the study, and no differences among groups were appreciated. However, in duodenum, the MVC+RAL group exhibited opposite effects to the EFV group on the naïve/memory CD8 T-cell ratio (Figure 1B, P=0.014), %naïve (P=0.018) and activated naïve CD8 T-cells (P=0.001), which increased in the MVC+RAL group but decreased in the EFV group. Similarly, peripheral CCR5+ CD4 and CD8 T cells significantly recovered up to normal levels in the MVC+RAL arm, while decreased in the EFV arm (MVC+RAL vs. EFV, P=0.003 and P=0.002, respectively).
Conclusions: These data suggest that quadruple ART including RAL+MVC may more effectively reach duodenum and improve systemic markers of innate immune activation and gut barrier. These therapeutic strategies deserve further assessment in clinical trials.